Acasti Pharma reported $-3360000 in Net Income for its fiscal quarter ending in June of 2025.


Net Income Change Date
Acasti Pharma USD -3360000 795K Jun/2025
Addus HomeCare USD 22.05M 824K Jun/2025
Amarin USD -15697000 32.92M Mar/2025
Cassava Sciences USD -44220000 16.62M Jun/2025
Knight Therapeutics CAD 85K 2.03M Sep/2024
Option Care Health USD 50.52M 3.78M Jun/2025
Organigram Holdings CAD -6290000 16.67M Jun/2025
Tilray USD -85342000 46.18M Nov/2024